Clinical trial Recruiting at 1 site Observational Ages 18 to 40

Impact of Aplastic Anemia on Reproductive and Mental Health

Official title: A Study on Reproductive and Psychological Health in Aplastic Anemia Patients

Run by Institute of Hematology & Blood Diseases Hospital, China · NCT06936930 · Data updated 2026-11-12

This study looks at how aplastic anemia and its treatments affect the reproductive and mental health of young adults aged 18-40.

More Reproductive Health trials

Quick facts

Study typeObservational
Ages18 Years to 40 Years
SexAll
Enrollment600 (estimated)
SponsorInstitute of Hematology & Blood Diseases Hospital, China
Academic / other
Drugs / interventionsChemotherapy, cyclophosphamide
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedMarch 3, 2025
Main results expectedOctober 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 5, 2025
Trial IDNCT06936930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are males and females aged 18-40 diagnosed with aplastic anemia and who meet specific health criteria.

Probably not a fit

Patients with inherited bone marrow failure syndromes or those with a history of severe psychological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with aplastic anemia (AA) to assess the effects of the disease and its treatments on reproductive health and mental well-being. It aims to monitor sex hormone levels in male and female patients aged 18-40 years, as reproductive health issues such as irregular menstruation and infertility are common among this population. The study will evaluate how treatments like immunosuppressive therapy may contribute to reproductive impairments. By understanding these impacts, the study seeks to provide insights into the overall health challenges faced by AA patients.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for reproductive health in patients with aplastic anemia.

How similar studies have gone: While there have been studies on reproductive health in other hematological conditions, this specific focus on aplastic anemia and its reproductive implications is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of AA
* Male or female, aged 18-40 years
* ECOG performance status ≤2
* Willing and able to comply with the requirements for this study and written informed consent

Exclusion Criteria:

* Diagnosis of inherited bone marrow failure syndromes
* Combined with other hematological diseases
* Chemotherapy-induced bone marrow failure
* Pregnant or breastfeeding women
* Subjects with a history of mental illness or severe psychological disorders
* Subjects with a history of reproductive system cancer (eg, penile cancer, testicular cancer, prostate cancer, ovarian cancer, cervical cancer, vaginal cancer, etc.)
* Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study

Where it's running

  • Regenerative Medicine Center
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.